Biểu đồ giá cổ phiếu STTK
STTK Tài chính
Shattuck Labs Inc
$6.85
9.42%
$0.58
Khi đóng cửa: May 08, 16:00:00 GMT-4
$6.72
-1.89%
$-0.12
Phiên sau giờ: May 08, 20:00:00 GMT-4
Quay lại
Shattuck Labs Inc (STTK) Tài chính
Thống kê chính
Giá đóng cửa trước
$6.26
Giá mở cửa
$6.37
Phạm vi ngày
$6.3 - $6.86
Phạm vi 52 tuần
$0.712 - $8.33
Khối lượng
1.5M
Khối lượng trung bình
611.2K
Tỷ suất cổ tức
--
EPS (TTM)
-0.77
Vốn hóa thị trường
$507.8M
STTK là gì?
Shattuck Labs, Inc. is a biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. The company is headquartered in Austin, Texas and currently employs 40 full-time employees. The company went IPO on 2020-10-09. The firm is engaged in the development of treatments for inflammatory and immune-mediated diseases. Its lead product candidate, SL-325, is a monoclonal antibody that is designed to bind to death receptor 3 (DR3) and inhibit its interaction with its ligand, TL1A. TL1A is a costimulatory ligand in the tumor necrosis factor superfamily, which activates immune responses through binding a single receptor, DR3. The firm is conducting a Phase I clinical trial in healthy volunteers. In addition, the Company is also developing SL-425, a half-life extended version of SL-325. The company is also developing multiple preclinical DR3-based bispecific antibodies, which are designed to inhibit both the DR3/TL1A axis and another biologically relevant target for the treatment of patients with inflammatory bowel disease.
